Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
Authors
Keywords
DNA vaccines, Cancer, Combination therapy, Immunotherapy, Immuno-oncology, Cancer vaccines, Antigens, Neoantigens
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-04-05
DOI
10.1186/s13046-019-1154-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge
- (2019) Elizabeth K. Duperret et al. Cancer Immunology Research
- Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
- (2019) Luigi Aurisicchio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Personalized neoantigen vaccines: A new approach to cancer immunotherapy
- (2018) Amanda R. Aldous et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
- (2018) Stephen J. Russell et al. CANCER CELL
- Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model
- (2018) Alex Allen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Present status and future perspective of peptide-based vaccine therapy for urological cancer
- (2018) Wataru Obara et al. CANCER SCIENCE
- Protective efficacy of a plasmid DNA vaccine against transgene-specific tumors by Th1 cellular immune responses after intradermal injection
- (2018) Hye-Youn Son et al. CELLULAR IMMUNOLOGY
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The perfect personalized cancer therapy: cancer vaccines against neoantigens
- (2018) Luigi Aurisicchio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MUC1- and Survivin-based DNA Vaccine Combining Immunoadjuvants CpG and interleukin-2 in a Bicistronic Expression Plasmid Generates Specific Immune Responses and Antitumour Effects in a Murine Colorectal Carcinoma Model
- (2018) C. Liu et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
- (2018) Jeffrey M. Clarke et al. Targeted Oncology
- Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
- (2018) Chung-Han Lee et al. TRENDS IN IMMUNOLOGY
- Enhancement of anti-tumor effect of plasmid DNA-carrying MUC1 by the adjuvanticity of FLT3L in mouse model
- (2018) Fu-Sheng Gao et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
- (2018) Alessandra Lopes et al. Scientific Reports
- Cripto-1 plasmid DNA vaccination targets metastasis and cancer stem cells in murine mammary carcinoma
- (2018) Kristina Witt et al. Cancer Immunology Research
- Of Mice, Dogs, Pigs, and Men: Choosing the Appropriate Model for Immuno-Oncology Research
- (2018) Nana H Overgaard et al. ILAR JOURNAL
- Perspective: cancer vaccines in the era of immune checkpoint blockade
- (2018) Jonathan Cebon MAMMALIAN GENOME
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
- (2018) Saman Maleki Vareki Journal for ImmunoTherapy of Cancer
- Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way
- (2017) Lucas Leite Cunha et al. ENDOCRINE-RELATED CANCER
- Making It Personal: Neoantigen Vaccines in Metastatic Melanoma
- (2017) Matthew D. Hellmann et al. IMMUNITY
- Neoepitopes as cancer immunotherapy targets: key challenges and opportunities
- (2017) Cory A Brennick et al. Immunotherapy
- The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy
- (2017) Suneetha Amara et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer
- (2017) Zishuo I. Hu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cytosolic nucleic acid sensors and innate immune regulation
- (2017) Daisuke Ori et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- The use of immunotherapy in the treatment of melanoma
- (2017) Tala Achkar et al. Journal of Hematology & Oncology
- A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses
- (2017) Wenbo Jiang et al. JOURNAL OF VIROLOGY
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- A Novel Recombinant Multi-Epitope Vaccine Could Induce Specific Cytotoxic T Lymphocyte Response In Vitro and In Vivo
- (2017) Yahong Wu et al. PROTEIN AND PEPTIDE LETTERS
- Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
- (2017) John J. Suschak et al. Human Vaccines & Immunotherapeutics
- Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations
- (2017) Margaret E. Gatti-Mays et al. Human Vaccines & Immunotherapeutics
- Human Tumor Antigens Yesterday, Today, and Tomorrow
- (2017) Olivera J. Finn Cancer Immunology Research
- Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8 + T Cells
- (2017) Jan Willem Kleinovink et al. Cancer Immunology Research
- Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma
- (2017) Alessandra Lopes et al. Molecular Therapy-Nucleic Acids
- Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
- (2017) Mirjana Efremova et al. Frontiers in Immunology
- Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy
- (2016) Maria Stella Sasso et al. BIOMATERIALS
- CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor model
- (2016) T Nguyen-Hoai et al. CANCER GENE THERAPY
- Anti-tumor effects of DNA vaccine targeting human fibroblast activation protein α by producing specific immune responses and altering tumor microenvironment in the 4T1 murine breast cancer model
- (2016) Qiu Xia et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination
- (2016) T. Ahrends et al. CANCER RESEARCH
- Mutational Landscape and Sensitivity to Immune Checkpoint Blockers
- (2016) R. M. Chabanon et al. CLINICAL CANCER RESEARCH
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma
- (2016) Qiu Xia et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Neoantigen heterogeneity: a key driver of immune response and sensitivity to immune checkpoint blockade?
- (2016) Andrew JS Furness et al. Immunotherapy
- DNA uptake, intracellular trafficking and gene transfection after ultrasound exposure
- (2016) Ying Liu et al. JOURNAL OF CONTROLLED RELEASE
- Protection against HPV-16-Associated Tumors Requires the Activation of CD8+ Effector Memory T Cells and the Control of Myeloid-Derived Suppressor Cells
- (2016) M. O. Diniz et al. MOLECULAR CANCER THERAPEUTICS
- Coadministration of a Plasmid Encoding HIV-1 Gag Enhances the Efficacy of Cancer DNA Vaccines
- (2016) Laure Lambricht et al. MOLECULAR THERAPY
- DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
- (2016) Angeliki Tiptiri-Kourpeti et al. PHARMACOLOGY & THERAPEUTICS
- Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines
- (2016) S.H.T. Jorritsma et al. VACCINE
- Immunogenicity and safety of xenogeneic vascular endothelial growth factor receptor-2 DNA vaccination in mice and dogs
- (2016) Sofie Denies et al. Oncotarget
- pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
- (2016) Jasreet Hundal et al. Genome Medicine
- SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade
- (2016) Wei Xue et al. OncoImmunology
- Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation
- (2016) Giuseppe V. Masucci et al. Journal for ImmunoTherapy of Cancer
- Synergistic antitumor efficacy of combined DNA vaccines targeting tumor cells and angiogenesis
- (2015) Xiaotao Yin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma
- (2015) Kathrin Mählmann et al. BMC Veterinary Research
- Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study
- (2015) Katy J. McCann et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model
- (2015) Euri Ahn et al. CANCER LETTERS
- Clinical potential of electroporation for gene therapy and DNA vaccine delivery
- (2015) Laure Lambricht et al. Expert Opinion on Drug Delivery
- Molecular mechanisms for enhanced DNA vaccine immunogenicity
- (2015) Lei Li et al. Expert Review of Vaccines
- Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen
- (2015) Luigi Aurisicchio et al. HUMAN GENE THERAPY
- BAP31, a promising target for the immunotherapy of malignant melanomas
- (2015) Shaojuan Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- In silico analyses of Wilms׳ tumor protein to designing a novel multi-epitope DNA vaccine against cancer
- (2015) Saeed Khalili et al. JOURNAL OF THEORETICAL BIOLOGY
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- Cluster analysis of quantitative parametric maps from DCE-MRI: application in evaluating heterogeneity of tumor response to antiangiogenic treatment
- (2015) Dario Livio Longo et al. MAGNETIC RESONANCE IMAGING
- Ubiquitin-like Molecule ISG15 Acts as an Immune Adjuvant to Enhance Antigen-specific CD8 T-cell Tumor Immunity
- (2015) Daniel O Villarreal et al. MOLECULAR THERAPY
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Anti-metastatic effects of DNA vaccine encoding single-chain trimer composed of MHC I and vascular endothelial growth factor receptor 2 peptide
- (2015) RUILING CHEN et al. ONCOLOGY REPORTS
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model
- (2015) Sachin Gupta et al. VACCINE
- The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation
- (2015) Gaëlle Vandermeulen et al. VACCINE
- PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization
- (2015) B. T. Rekoske et al. Cancer Immunology Research
- Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen
- (2015) Boya Zhong et al. Journal of Immunology Research
- RNA-Based Vaccines in Cancer Immunotherapy
- (2015) Megan A. McNamara et al. Journal of Immunology Research
- Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8+T-cell responses and immune memory
- (2015) Junjie Wu et al. OncoImmunology
- Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes
- (2014) S. D. Soysal et al. BREAST CANCER RESEARCH AND TREATMENT
- Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients
- (2014) S. Occhipinti et al. CLINICAL CANCER RESEARCH
- Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer
- (2014) V. Tiriveedhi et al. CLINICAL CANCER RESEARCH
- Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice
- (2014) Pier Ruffini et al. Journal of Translational Medicine
- A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients
- (2014) J Bae et al. LEUKEMIA
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design of a Highly Effective Therapeutic HPV16 E6/E7-Specific DNA Vaccine: Optimization by Different Ways of Sequence Rearrangements (Shuffling)
- (2014) Fahad N. Almajhdi et al. PLoS One
- Tumor antigen-specific CD4+T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies
- (2014) M. P. Protti et al. TISSUE ANTIGENS
- Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use?
- (2014) Marius M. Strioga et al. VACCINE
- Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
- (2014) Tae Jin Kim et al. Nature Communications
- Implication of human herpesviruses in oncogenesis through immune evasion and supression
- (2014) Kenneth Alibek et al. Infectious Agents and Cancer
- Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo
- (2014) Linda C Sandin et al. OncoImmunology
- Live-attenuated bacteria as a cancer vaccine vector
- (2013) Bertrand Toussaint et al. Expert Review of Vaccines
- Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors
- (2013) Claudia Marcela Diaz-Montero et al. Journal of Translational Medicine
- Xenogeneic Human p53 DNA Vaccination by Electroporation Breaks Immune Tolerance to Control Murine Tumors Expressing Mouse p53
- (2013) Ruey-Shyang Soong et al. PLoS One
- DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer
- (2013) Fredrik Eriksson et al. VACCINE
- T-cell adoptive immunotherapy for acute lymphoblastic leukemia
- (2013) T. J. Fry et al. Hematology-American Society of Hematology Education Program
- Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
- (2013) Jianda Yuan et al. Journal for ImmunoTherapy of Cancer
- Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer
- (2012) Andreas G Niethammer et al. BMC CANCER
- Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells
- (2012) Venkataswarup Tiriveedhi et al. BREAST CANCER RESEARCH AND TREATMENT
- Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway
- (2012) Yuying Wei et al. JOURNAL OF GENE MEDICINE
- Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice
- (2012) Alexandra Sevko et al. Journal of Immunotoxicology
- Therapeutic Cancer Vaccines: Current Status and Moving Forward
- (2012) J. Schlom JNCI-Journal of the National Cancer Institute
- Harnessing DNA-induced immune responses for improving cancer vaccines
- (2012) Andrés A. Herrada et al. Human Vaccines & Immunotherapeutics
- Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor
- (2011) Deborah A. Grosenbaugh et al. AMERICAN JOURNAL OF VETERINARY RESEARCH
- Design of immunogenic and effective multi-epitope DNA vaccines for melanoma
- (2011) Hyun-Il Cho et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Precursor Frequency and Competition Dictate the HLA-A2-Restricted CD8+ T Cell Responses to Influenza A Infection and Vaccination in HLA-A2.1 Transgenic Mice
- (2011) A. C. L. Tan et al. JOURNAL OF IMMUNOLOGY
- Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans
- (2011) Elena Quaglino et al. Cancers
- Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer
- (2010) A Wu et al. GENE THERAPY
- TAA Polyepitope DNA-Based Vaccines: A Potential Tool for Cancer Therapy
- (2010) Roberto Bei et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- CD4+ TH1 Cells Generated by Ii-PADRE DNA at Prime Phase Are Important to Induce Effectors and Memory CD8+ T Cells
- (2010) Jae Yeo Park et al. JOURNAL OF IMMUNOTHERAPY
- Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients
- (2009) D. Generali et al. CLINICAL CANCER RESEARCH
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Intracellular detection and immune signaling pathways of DNA vaccines
- (2009) Choon-Kit Tang et al. Expert Review of Vaccines
- Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope
- (2009) Yong Lu et al. VACCINE
- Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors
- (2008) Y Gao et al. CANCER GENE THERAPY
- Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
- (2008) J. H. Finke et al. CLINICAL CANCER RESEARCH
- Induction of Multiepitopic and Long-Lasting Immune Responses Against Tumour Antigens by Immunization with Peptides, DNA and Recombinant Adenoviruses Expressing Minigenes
- (2008) M. Durántez et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More